Company News in the Life Science Industry

»

Reset 

Debbie's Dream Foundation Honors Legacy of Founder Debbie Zelman at Sold Out 9th Annual Night of Laughter

DAVIE, Fla., Feb. 16, 2018 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) hosted a sold-out show of more than 400 guests and raised more than $73,000 for stomach cancer research at its ninth annual Night of Laughter. The event was held at the Signature Grand in Davie,... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Data Shows Positive Projections for the Legal Cannabis Market in North America

NEW YORK, February 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  Vitality Biopharma

Global Gene Therapy Market Expected to Reach $4,402 Million by 2023 - Allied Market Research

PORTLAND, Oregon and PUNE, India, February 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  Allied Market Research

Future Legal Cannabis Sales Projected to Increase

NEW YORK, February 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Cardiac Assist Devices Market is Expected to Reach a Market Value of Over US$ 2,200 Mn by the end of 2027

VALLEY COTTAGE, New York, February 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Global Gastric Cancer Forecast and Market Analysis 2017-2024: Forecasts, Treatment, Epidemiology, Marketed Drugs, Pricing & Reimbursement and Piepline

DUBLIN, Feb. 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

RSV Diagnostics Market Worth 929.2 Million USD by 2022

PUNE, India, February 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Brewer Science Rolls Out End-to-End Printed Electronics System Integration Services

MONTEREY, Calif., Feb. 16, 2018 /PRNewswire-iReach/ -- Feb. 15, 2018 - Brewer Science, Inc., today launched its Sensor System Solutions program at the 2018 Flexible Electronics Conference. The new offering provides full consulting services to support customers from design through integration,... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

On-Demand Healthcare Provider DispatchHealth Hires Healthcare Veterans to Lead Sales and Marketing

DENVER, Feb. 16, 2018 /PRNewswire/ -- DispatchHealth, a Denver-based healthcare company that delivers on-demand, acute healthcare services in-home and at senior living communities in five markets, today announced it... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Glenmark Pharmaceuticals Presents New Data on GBR 830, a First-in-Class, Investigational, Anti-OX40 Monoclonal Antibody for the Treatment of Moderate-to-Severe Atopic Dermatitis at the 2018 American Academy of Dermatology Annual Meeting

PARAMUS, N.J., Feb. 16, 2018 /PRNewswire/ -- Glenmark Pharmaceuticals, a global pharmaceutical company, today presented findings from a Phase 2a study of GBR 830, an investigational anti-OX40 monoclonal antibody, at the 2018 American Academy of Dermatology (AAD) Annual Meeting in San Diego. The... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

New TREMFYA® (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis

SAN DIEGO, Feb. 16, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA(®) (guselkumab) who achieved at least 90 percent improvement in the... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Global Chronic Myeloid Leukemia (CML) Market Report 2017: Focus on Forecasts, Treatment, Epidemiology, Marketed Drugs & Pipeline

DUBLIN, Feb. 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting

SKILLMAN, N.J., Feb. 16, 2018 /PRNewswire/ -- Reinforcing leadership in scientifically-driven skincare, Johnson & Johnson Consumer Inc. will present eight Scientific Posters at this year's American Academy... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  Johnson & Johnson

UCB Advances Psoriasis Pipeline with Positive Data at American Academy of Dermatology Annual Meeting (AAD 2018)

BRUSSELS, Feb. 16, 2018 /PRNewswire/ -- UCB, a global biopharmaceutical company, will be presenting new data on CIMZIA(®) (certolizumab pegol) and one of UCB's key pipeline molecules, bimekizumab, at the 2018 American Academy of Dermatology (AAD) Annual Meeting in San Diego, CA (February 16-20,... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  UCB Inc. (US)

BirchBioMed is cleared to begin first-of-its-kind phase II clinical trial for ground-breaking anti-scarring drug

BirchBioMed Inc. is exclusively licensed by the University of British Columbia to develop anti-scarring drugs and autoimmune therapies based on its leading drug candidate, FS2

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

BioAmber Inc. Receives Notice of Delisting by TSX

MONTREAL, Feb. 16, 2018 /PRNewswire/ - BioAmber Inc. (OTCPK: BIOA) announced today that the Toronto Stock Exchange (TSX) has notified the Company that it has determined to suspend trading in the Company's shares of common stock, effective February 16, 2018, and to delist the Company's securities... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  BioAmber Inc.

Ortho Dermatologics Presents An Analysis Of SILIQ(TM) (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depression In Patients With Moderate-To-Severe Plaque Psoriasis

Separate Phase 3 Analysis Highlights Long-Term Safety Profile of SILIQ

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  Valeant Pharmaceuticals International, Inc.

Avillion Advances Co-development Programme with Merck: IND Now Open for Phase 2 Study of M1095, an Anti-IL-17 A/F Nanobody® in Psoriasis

LONDON, February 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Prometic Announces Publication of PBI-4050's Novel Antifibrotic Mechanism of Action in American Journal of Pathology

LAVAL, QC, Feb. 16, 2018 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic") today announced the publication in the American Journal of Pathology, the official journal of the American Society of Investigational Pathology, of the novel antifibrotic... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Insight Venture Partners invests in CentralReach

POMPANO BEACH, Fla., Feb. 16, 2018 /PRNewswire/ -- CentralReach, the premier provider of electronic health record and practice management software for clinics focused on applied behavioral analysis (ABA) and speech therapy, has received a significant investment from Insight Venture Partners ("Insight"),... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies